anonymous
Guest
anonymous
Guest
What is up with all the hemophilia CS job postings?
I could reply one of two ways:What is up with all the hemophilia CS job postings?
We all know it's a new sales team but the salary / call plan sucks, no company car, no indication of the territory size, product is not approved, etc. offers won't go out until May. What's the motivation to get on board?
You seem to know the salary/call plan. Do tell, what is it?We all know it's a new sales team but the salary / call plan sucks, no company car, no indication of the territory size, product is not approved, etc. offers won't go out until May. What's the motivation to get on board?
You have no idea what you're talking about. There are 10+ positions recently posted and I've started the interview process for one of those three days ago. Now who's the troll?They were filled a month ago. Crawl back in that cave troll and try again.
That's where your wrong, kingasabi. Sales are not important. This is not a sales org, rather a development org. People get promoted all the time with horrible sales results. It's all about "who you know ".Remember this post- Genentech has no idea what kind of market they are entering. I feel sorry for the first reps who take this job, they will be blamed for the slow uptake of conversions. If you want this job, wait for the smoke to clear in a year and the company realizes this market is totally patient driven.
Tell the patients who passed away during the trial that this drug is "best in class"I was told in the phone screen salary is 120k-160k depending on experience. This will be a very tough position to get if not already employed by Genentech. Lots of internal candidates for the few positions. Commission plan hasn't been approved yet but at goal will be north of 40k. They are well aware that this market is patient driven- however this is by far the best in class product so times will be changing!
Correction Troll - one passed away and it was determined not directly attributable to Hemlibra. No drug is perfect so if it offers even a minimal improvement in quality of life for a disease like this, then let the patients decide.Tell the patients who passed away during the trial that this drug is "best in class"
are they interviewing? ive applied and havent heard anything